ALDER BIOPHARMACEUTICALS INC - COM (ALDR)

Historical Holders from Q2 2014 to Q4 2019

Type / Class
Equity / COM
Symbol
ALDR
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ALDER BIOPHARMACEUTICALS INC - COM (ALDR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2019 Q4 0 $0 -$1,751,265,181 0
2019 Q3 92,905,899 $1,752,194,329 +$158,901,633 $18.86 142
2019 Q2 89,995,146 $1,058,985,515 +$56,996,873 $11.77 123
2019 Q1 88,353,816 $1,205,942,764 +$235,464,081 $13.65 116
2018 Q4 71,553,935 $733,427,881 -$22,762,675 $10.25 118
2018 Q3 71,313,910 $1,187,570,279 +$24,922,269 $16.65 125
2018 Q2 70,004,648 $1,106,066,687 -$1,103,158 $15.80 136
2018 Q1 70,335,073 $893,236,744 +$42,360,526 $12.70 129
2017 Q4 67,285,547 $770,471,877 -$1,085,860 $11.45 131
2017 Q3 65,598,745 $802,819,737 +$159,939,448 $12.25 126
2017 Q2 51,099,239 $585,104,219 +$13,640,145 $11.45 123
2017 Q1 52,850,201 $1,099,496,267 +$65,042,662 $20.80 141
2016 Q4 53,507,479 $1,112,962,950 -$19,407,367 $20.80 140
2016 Q3 53,004,129 $1,736,029,929 -$24,504,359 $32.77 157
2016 Q2 53,260,910 $1,329,650,614 +$210,595,949 $24.97 141
2016 Q1 44,971,356 $1,100,796,248 +$112,137,455 $24.49 115
2015 Q4 40,349,533 $1,333,388,115 +$86,141,630 $33.03 135
2015 Q3 37,349,298 $1,222,644,655 +$126,172,258 $32.76 138
2015 Q2 32,021,258 $1,694,771,122 +$548,920,389 $52.97 128
2015 Q1 22,008,412 $634,947,726 +$253,803,653 $28.86 89
2014 Q4 13,189,565 $383,673,352 -$1,964,207 $29.09 73
2014 Q3 12,894,211 $163,494,035 +$22,845,850 $12.68 57
2014 Q2 10,957,287 $219,908,026 +$219,894,090 $20.07 48